Thorsten Maretzky

Title: Thorsten Maretzky: Innovator in EGFR Dependent Pathologies

Introduction

Thorsten Maretzky is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of EGFR dependent pathologies. His innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Maretzky holds a patent titled "Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2." This patent discloses methods for treating subjects with EGFR dependent pathologies. The method involves administering an effective amount of a 'First Agent' that decreases the biological activity of iRhom1 and a 'Second Agent' that decreases the biological activity of iRhom2. Additionally, the patent outlines alternative methods that modulate the formation of complexes between iRhom1, TACE, and iRhom2. Maretzky's patent is a testament to his innovative thinking and dedication to advancing medical treatments. He has 1 patent to his name.

Career Highlights

Throughout his career, Maretzky has worked with esteemed institutions such as the Hospital for Special Surgery and the University Health Network. His work in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and contributions to medical science.

Collaborations

Maretzky has collaborated with notable professionals, including Carl Peter Blobel and David McIlwain. These partnerships have played a crucial role in the development of his research and patents.

Conclusion

Thorsten Maretzky is a distinguished inventor whose work has significantly impacted the treatment of EGFR dependent pathologies. His innovative patent and collaborations with leading experts highlight his commitment to advancing medical research and improving patient outcomes.